Is hydroxychloroquine effective for treating idiopathic burning mouth syndrome in an adult without autoimmune disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Hydroxychloroquine is NOT Effective for Burning Mouth Syndrome

Hydroxychloroquine has no established role in treating idiopathic burning mouth syndrome (BMS) and should not be used for this indication. There is no evidence—neither in clinical trials nor in treatment guidelines—supporting its efficacy for BMS, and the drug carries significant risks that are unjustifiable without proven benefit.

Why Hydroxychloroquine is Not Indicated

Complete Absence of Evidence

  • No studies have evaluated hydroxychloroquine for BMS treatment. Comprehensive reviews of BMS therapies spanning 15-20 years of literature identify multiple treatment modalities including antidepressants, alpha-lipoic acid, clonazepam, capsaicin, anticonvulsants, cognitive therapy, and laser therapy—but hydroxychloroquine is never mentioned as a therapeutic option 1, 2, 3, 4, 5.

  • The systematic review of BMS treatment modalities analyzed 29 randomized clinical trials published between 1996-2016, categorizing treatments into antidepressants, alpha-lipoic acid, phytotherapeutic agents, analgesic/anti-inflammatory agents, and non-pharmacological therapies—hydroxychloroquine appears in none of these categories 5.

Mechanism Mismatch

  • Hydroxychloroquine's pharmacologic actions do not address BMS pathophysiology. Hydroxychloroquine is an antimalarial and immunomodulatory agent used for autoimmune conditions like systemic lupus erythematosus and rheumatoid arthritis 6, 7.

  • BMS is a neuropathic pain disorder, not an autoimmune or inflammatory condition. Primary (idiopathic) BMS is characterized by burning sensation without clinically apparent mucosal alterations or underlying autoimmune pathology 3.

  • The European League Against Rheumatism guidelines recommend hydroxychloroquine for Sjögren's syndrome but explicitly state it does NOT improve subjective or objective oral dryness outcomes—the closest oral symptom to BMS studied 6.

Significant Risks Without Benefit

Retinal Toxicity

  • Irreversible vision loss can occur after >2 years of continuous use due to chloroquine retinopathy, the most serious long-term adverse effect 7.

  • Baseline ophthalmologic examination is mandatory before initiating therapy, with annual screening beginning after 5 years for low-risk patients 7.

Other Adverse Effects

  • Common side effects include gastrointestinal disturbance, headache, dizziness, blurred vision, and pruritus 7.

  • QT interval prolongation requires baseline ECG monitoring 7.

  • Rare but serious effects include elevated liver enzymes, exacerbation of psoriasis, and cardiac toxicity 7.

  • The drug is absolutely contraindicated in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency 7.

Evidence-Based Treatment Algorithm for BMS

First-Line Approaches

  • Topical clonazepam shows good short-term results for pain relief, though not a definitive cure 4.

  • Alpha-lipoic acid demonstrates good results in multiple studies, though long-term data on complete symptom remission remain limited 4, 5.

Second-Line Options

  • Antidepressants (tricyclic antidepressants like amitriptyline, or duloxetine) show promising results in systematic reviews 1, 5.

  • Anticonvulsants (gabapentin or pregabalin) are established options 1.

  • Low-dose aripiprazole has emerging evidence 1.

Adjunctive Therapies

  • Cognitive behavioral therapy is reported as a good and lasting therapeutic option with no side effects, and can be combined with pharmacologic therapy 4.

  • Capsaicin (topical) has evidence from randomized controlled trials 3.

Critical Diagnostic Step

  • Rule out secondary causes before diagnosing primary BMS: vitamin deficiencies (B12, folate, iron), zinc deficiency, hormonal changes, xerostomia, oral candidiasis, geographic tongue, lichen planus, medication side effects, and psychological factors 3.

  • When local, systemic, or psychological factors are identified and treated, significant clinical improvement usually occurs 3.

Common Pitfall to Avoid

Do not prescribe hydroxychloroquine simply because a patient with BMS has positive autoantibodies (ANA, anti-Ro/La, RF) without meeting criteria for systemic autoimmune disease. Isolated autoantibody positivity does not reliably predict clinical disease, and there is no evidence that hydroxychloroquine alters this natural history 8. The monitoring burden and toxicity risks are unjustifiable in asymptomatic individuals or those with BMS alone 8.

References

1
Research

Burning mouth syndrome: a review of therapeutic approach.

Journal of complementary & integrative medicine, 2021

2
Research

Burning mouth syndrome: Identification, diagnosis, and treatment.

Journal of the American Academy of Nurse Practitioners, 2009

3
Research

Burning mouth syndrome: a review and update.

Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2013

4
Research

Therapeutic options in idiopathic burning mouth syndrome: literature review.

International archives of otorhinolaryngology, 2015

7
Guideline

Hydroxychloroquine Side Effects and Monitoring

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

8
Guideline

Hydroxychloroquine in Subclinical Autoimmunity – Evidence Summary

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the recommended approach to using steroids, such as prednisolone, in an older adult patient with burning mouth syndrome and potential risk factors for steroid-induced side effects like osteoporosis, diabetes, and hypertension?
Could recurrent red lips, burning, pain, minimal swelling, and irritation in a patient be caused by a B12 (cobalamin), folate, or zinc deficiency?
What are the differential diagnoses for a persistent burning sensation on the tongue with normal iron and vitamin B12 levels and no oral lesions?
How do I diagnose and manage burning mouth syndrome (idiopathic burnt tongue)?
Which specialist should assess a patient with a burning tongue (burning mouth syndrome)?
Is it safe to combine losartan (100 mg) with chlortalidone (50 mg)?
What is the reporting cutoff concentration for amphetamines on the standard Quest Diagnostics urine immunoassay drug screen?
How often are anti‑rabies vaccine booster doses required for routine pre‑exposure prophylaxis in high‑risk individuals, and what is the recommended post‑exposure booster schedule for previously vaccinated persons?
What is a vaginal hysterectomy, including its indications, surgical technique, advantages, and potential complications?
Which antipsychotic medication is safest for a breastfeeding mother?
In a 33‑year‑old woman with perioral seborrheic dermatitis prescribed ketoconazole 2% cream, who uses a daily heating pad, spironolactone for cystic hormonal acne, and currently uses CeraVe cleanser/moisturizer, a vitamin C serum, retinol, and a honey‑based moisturizer, how often and how thickly should the ketoconazole cream be applied, and which of her other skincare products are safe to use without worsening the dermatitis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.